Barclays Maintains Equal-Weight on Qiagen, Raises Price Target to $40

Benzinga · 1d ago
Barclays analyst Luke Sergott maintains Qiagen (NYSE:QGEN) with a Equal-Weight and raises the price target from $38 to $40.